Psychoneurotic clinical trials are difficult due to the complex etiology and symptoms of psychoneurotic diseases, and often lack of reliable biological markers. In addition, psychoneurotic trials involve sensitive issues such as patient privacy and ethics, which require strict compliance with ethical regulations. There are also challenges in patient screening, data collection and analysis, and interpretation of results, requiring strict control over the design and execution of trials to ensure the reliability and validity of study results.
Alzheimer's disease
Insomnia disorder
Depressive disorder
Schizophrenia
Parkinsonism